Alaunos Therapeutics, Inc. - Common Stock (TCRT)
3.9900
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 10th, 4:07 AM EDT
Via Benzinga · October 9, 2025
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.
Via Benzinga · October 9, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · October 9, 2025
Via Benzinga · October 9, 2025
Via Benzinga · October 9, 2025
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
Via Benzinga · September 3, 2025
Via Benzinga · June 23, 2025
Via Benzinga · June 16, 2025
Via Benzinga · June 6, 2025
iCoreConnect, BioAffinity and Alaunos Therapeutics posted strong gains last week amid heavy trading volume.
Via Stocktwits · April 7, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · April 3, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · April 3, 2025
Via Benzinga · April 3, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · April 2, 2025
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · April 2, 2025
Via Benzinga · April 2, 2025

Alaunos Therapeutics just reported results for the second quarter of 2024.
Via InvestorPlace · August 16, 2024

Via Benzinga · July 18, 2024

Via Benzinga · June 21, 2024

Via Benzinga · June 20, 2024

Alaunos Therapeutics just reported results for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

TCRT stock results show that Alaunos Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 8, 2024

Via Benzinga · February 14, 2024